Immudicon Educating Immune Cells
OVERVIEW
IMMUDICON.COM TRAFFIC
Date Range
Date Range
Date Range
IMMUDICON.COM HISTORY
SITE AGE
LINKS TO DOMAIN
WHAT DOES IMMUDICON.COM LOOK LIKE?
CONTACTS
Domains By Proxy, LLC
Registration Private
DomainsByProxy.com 14747 N Northsight Blvd Suite 111, PMB 309
Scottsdale, Arizona, 85260
United States
IMMUDICON.COM SERVER
NAME SERVERS
BROWSER ICON
HTML TITLE
Immudicon Educating Immune CellsDESCRIPTION
Immudicon is a biotech startup creating complement-based biologics that localize immune cells to the tumor in conjunction with Novartis and the NIH.PARSED CONTENT
The domain immudicon.com had the following on the web page, "CNN, American Association for Cancer Research, Google X, the Milken Institute, TEDxJohnson." We observed that the website said " Johnson, MassChallenge, the American Society of Microbiology, Verizon Powerful Answers, and the National Young Inventors Gallery." It also stated " We are testing several complement-based fusion proteins and have found that via these pathways we can induce a tumor-specific cytotoxic T cell response. RT-PCR studies on human dendritic cells shows our technology downregulates genes that shut down the immune system." The header had Immudicon as the highest ranking keyword. This keyword was followed by antibodies, biotechnology, and cancer immunology which isn't as urgent as Immudicon. The other words the site used was immuno-oncology. immunology is also included but will not be viewed by search engines.SEEK OTHER WEBSITES
Die immuG Rohr Schlauch GmbH ist ein mittelständisches Unternehmen mit Sitz in Walbeck. Wir produzieren ausschließlich an diesem Standort Schläuche, Rohre und Teile für den Anlagenbau aus Gummi. Wir planen und bauen Verrohrungen für Anlagen, liefern Schläuche und beraten unsere Kunden zum optimalen Einsatz der Produkte. Unsere Produkte finden ihre Einsatzgebiete in der Grundstoffindustrie, im Bergbau, in der Chemie, in der Elektrotechnik und Umwelttechnik.
Sunday, September 14, 2008. Colostrum is free from hormones, pesticides and antibiotics. Made without fillers, every batch of ImmuGain.
Widespread use of cannabis in Jamaica and the low prevalence of HIV disease. The Company was founded in 1999 based on this observation. Two non-psychoactive cannabinoids are in the development pipeline. A New Paradigm in the Treatment and Prevention of HIV disease. Our drugs target the peripheral cannabinoid receptors which are expressed in the immune system, vaginal tissue and intestinal mucosa leading to a quiescent. State which is unfavorable for HIV transmission and replication.